Skip to content

Coaching for HCV and HIV

Peer Recovery Coaching to Facilitate Comprehensive HCV, HIV and Opioid Use Disorder Treatment: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04314414
Enrollment
31
Registered
2020-03-19
Start date
2020-12-20
Completion date
2022-01-28
Last updated
2022-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C, HIV Infections, Opioid-use Disorder

Keywords

Peer recovery coach (PRC), Pre-exposure prophylaxis (PrEP), HIV care, HCV care, Low-barrier-to-access (LBA)

Brief summary

The objective of this study is to determine the feasibility and acceptability of a peer recovery coach (PRC) intervention to improve linkage to hepatitis C (HCV) and/or human immunodeficiency virus (HIV) care, treatment initiation, and evaluation for HIV pre-exposure prophylaxis (PrEP) (when applicable) among individuals with a history of opioid use disorder accessing a substance use low-barrier-to-access (LBA) walk-in clinic. In-depth interviews will be administered to participants at baseline, three- and six-months for study participants (40 total participants). The investigator will also follow-up with the per recovery coach and administer surveys to assess the feasibility of a peer recovery coaching intervention in improving HCV/HIV related linkage to care and management. Patient medical records and peer recovery coach monthly reports will be accessed and reviewed to determine fidelity to research protocols.

Detailed description

\*NOTE\* Due to the COVID-19 pandemic, surveys were conducted via telephone and not all participants could be contacted. Therefore, the number of results from participants at three months and six months vary. The data gathered are from participants that were reachable and completed the surveys.

Interventions

OTHERPRC brief motivational interview intervention

The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing.

The PRC will remain in at least weekly contact by phone with each participant.

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Boston University
CollaboratorOTHER
Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals with opioid use disorder, non-reactive HIV antibody test and reactive HCV antibody testing at the BMC LBA walk-in clinic * Able to speak English * Individuals providing contact information of two family members or friends * Individuals signing a medical records release form

Exclusion criteria

* Individuals already linked to substance use care * Individuals co-infected with HIV and HCV and engaged in care

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of Intervention6 monthsAs part of an investigator developed survey a 5-point LIkert scale question will be asked on how acceptable the intervention/care was where 1 is not acceptable and 5 is very acceptable.

Secondary

MeasureTime frameDescription
Participant Linkage to HCV Care6 monthsParticipants will be interviewed and asked investigator developed questions about linkage to HCV care
Participant Linkage to Care for Opioid Use3 months and 6 monthsParticipants will be interviewed and asked investigator developed questions about their linkage to care for opioid use
Participant Linkage to HIV Care3 months and 6 monthsParticipants will be interviewed and asked investigator developed questions about linkage to HIV care
Number of Participants Who Received HCV Care6 monthsWhether participants received HCV care will be abstracted from their electronic medical records (EMR) system.
Number of Participants Who Received Opioid Use Treatment6 monthsWhether participants received opioid use treatment will be abstracted from their electronic medical records (EMR) system.
Number of Participants Who Received Pre-exposure Prophylaxis (PrEP)6 monthsWhether participants received PrEp treatment will be abstracted from their electronic medical records (EMR) system.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention Group
Participants in the intervention group will receive a semi-scripted brief motivational interview from the peer recovery coach (PRC) in addition to the standard of care at Boston Medical Center (BMC) for HIV, HCV, and opioid use disorder. PRC brief motivational interview intervention: The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing. Phone contact: The PRC will remain in at least weekly contact by phone with each participant.
31
Total31

Baseline characteristics

CharacteristicIntervention Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
23 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply)
American Indian or Alaska Native
2 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply)
Asian
0 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply)
Black or African American
3 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply)
Hispanic/Latinx
8 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply)
Native Hawaiian or Pacific Islander
1 Participants
Race/Ethnicity, Customized
How would you describe your racial/ethnic identity? (check all that apply)
White
17 Participants
Region of Enrollment
United States
31 participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
21 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 31
other
Total, other adverse events
0 / 31
serious
Total, serious adverse events
0 / 31

Outcome results

Primary

Acceptability of Intervention

As part of an investigator developed survey a 5-point LIkert scale question will be asked on how acceptable the intervention/care was where 1 is not acceptable and 5 is very acceptable.

Time frame: 6 months

Population: 20 out of the 29 participants that were retained at 6 months, completed the 6 month satisfaction survey. 9 Participants were unreachable at 6 months.~Only 14 participants were asked about the cell phones as it was added later in the study.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention GroupAcceptability of InterventionIntervention was helpfulSatisfied/Agreed3 Participants
Intervention GroupAcceptability of InterventionLived-Experience of Peer Recovery Had Positive ImpactVery Satisfied/Strongly Agreed15 Participants
Intervention GroupAcceptability of InterventionLived-Experience of Peer Recovery Had Positive ImpactSatisfied/Agreed4 Participants
Intervention GroupAcceptability of InterventionLived-Experience of Peer Recovery Had Positive ImpactNeither Satisfied nor Dissatisfied/NA0 Participants
Intervention GroupAcceptability of InterventionSatisfaction working with Peer Recovery CoachVery Satisfied/Strongly Agreed13 Participants
Intervention GroupAcceptability of InterventionSatisfaction working with Peer Recovery CoachSatisfied/Agreed6 Participants
Intervention GroupAcceptability of InterventionSatisfaction working with Peer Recovery CoachNeither Satisfied nor Dissatisfied/NA0 Participants
Intervention GroupAcceptability of InterventionSatisfaction working with Peer Recovery CoachDissatisfied/Disagreed0 Participants
Intervention GroupAcceptability of InterventionSatisfaction working with Peer Recovery CoachVery Dissatisfied/Strongly Disagreed1 Participants
Intervention GroupAcceptability of InterventionIntervention was helpfulVery Satisfied/Strongly Agreed16 Participants
Intervention GroupAcceptability of InterventionIntervention was helpfulNeither Satisfied nor Dissatisfied/NA1 Participants
Intervention GroupAcceptability of InterventionIntervention was helpfulDissatisfied/Disagreed0 Participants
Intervention GroupAcceptability of InterventionIntervention was helpfulVery Dissatisfied/Strongly Disagreed0 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Navigation to Substance Use Programs/ResourcesVery Satisfied/Strongly Agreed15 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Navigation to Substance Use Programs/ResourcesSatisfied/Agreed4 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Navigation to Substance Use Programs/ResourcesNeither Satisfied nor Dissatisfied/NA0 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Navigation to Substance Use Programs/ResourcesDissatisfied/Disagreed0 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Navigation to Substance Use Programs/ResourcesVery Dissatisfied/Strongly Disagreed1 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Access to HIV Prevention and PrEPVery Satisfied/Strongly Agreed12 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Access to HIV Prevention and PrEPSatisfied/Agreed7 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Access to HIV Prevention and PrEPNeither Satisfied nor Dissatisfied/NA1 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Access to HIV Prevention and PrEPDissatisfied/Disagreed0 Participants
Intervention GroupAcceptability of InterventionPeer Recovery Coach Provided Access to HIV Prevention and PrEPVery Dissatisfied/Strongly Disagreed0 Participants
Intervention GroupAcceptability of InterventionHelpfulness of PhoneVery Satisfied/Strongly Agreed12 Participants
Intervention GroupAcceptability of InterventionHelpfulness of PhoneSatisfied/Agreed2 Participants
Intervention GroupAcceptability of InterventionHelpfulness of PhoneNeither Satisfied nor Dissatisfied/NA0 Participants
Intervention GroupAcceptability of InterventionHelpfulness of PhoneDissatisfied/Disagreed0 Participants
Intervention GroupAcceptability of InterventionHelpfulness of PhoneVery Dissatisfied/Strongly Disagreed0 Participants
Intervention GroupAcceptability of InterventionLived-Experience of Peer Recovery Had Positive ImpactDissatisfied/Disagreed0 Participants
Intervention GroupAcceptability of InterventionLived-Experience of Peer Recovery Had Positive ImpactVery Dissatisfied/Strongly Disagreed1 Participants
Secondary

Number of Participants Who Received HCV Care

Whether participants received HCV care will be abstracted from their electronic medical records (EMR) system.

Time frame: 6 months

Population: Only 9 participants were eligible for HCV as they tested positive.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention GroupNumber of Participants Who Received HCV CareNumber of participants engaged in HCV treatment at the time of enrollment0 Participants
Intervention GroupNumber of Participants Who Received HCV CareNumber of participants receiving or had completed HCV treatment at 6 months.2 Participants
Secondary

Number of Participants Who Received Opioid Use Treatment

Whether participants received opioid use treatment will be abstracted from their electronic medical records (EMR) system.

Time frame: 6 months

Population: 22 participants were already on a medications for opioid use disorder (MOUD) before enrollment. Of the total number of participants analyzed, 6 started a MOUD on the day of the enrollment.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention GroupNumber of Participants Who Received Opioid Use TreatmentNumber of participants that started MOUD on the day of enrollment.6 Participants
Intervention GroupNumber of Participants Who Received Opioid Use TreatmentNumber of participants who were on MOUD at the time of enrollment.22 Participants
Intervention GroupNumber of Participants Who Received Opioid Use TreatmentNumber of participants on MOUD at 6 months after enrollment15 Participants
Intervention GroupNumber of Participants Who Received Opioid Use TreatmentNumber of participants on MOUD at enrollment and remained on through the end of the intervention13 Participants
Secondary

Number of Participants Who Received Pre-exposure Prophylaxis (PrEP)

Whether participants received PrEp treatment will be abstracted from their electronic medical records (EMR) system.

Time frame: 6 months

Population: Of all 29 participants at 6 months, only 14 were eligible to initiate PrEP.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention GroupNumber of Participants Who Received Pre-exposure Prophylaxis (PrEP)Number of participants that started PrEP during the intervention5 Participants
Intervention GroupNumber of Participants Who Received Pre-exposure Prophylaxis (PrEP)Number of participants on PrEP at 6 months6 Participants
Secondary

Participant Linkage to Care for Opioid Use

Participants will be interviewed and asked investigator developed questions about their linkage to care for opioid use

Time frame: 3 months and 6 months

Population: At 3 months, not all participants were contactable. 16 participants out of 31 completed the satisfaction survey.~At 6 months, not all participants were contactable. 20 participants out of 29 completed the satisfaction survey.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention GroupParticipant Linkage to Care for Opioid Use3 Months: The PRC provided adequate navigation to substance use programs and/or resources.Strongly Agree10 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use3 Months: The PRC provided adequate navigation to substance use programs and/or resources.Agree6 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use3 Months: The PRC provided adequate navigation to substance use programs and/or resources.Neither or N/A0 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use3 Months: The PRC provided adequate navigation to substance use programs and/or resources.Disagree0 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use3 Months: The PRC provided adequate navigation to substance use programs and/or resources.Strongly Disagree0 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use6 Months: The PRC provided adequate navigation to substance use programs and/or resources.Strongly Agree15 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use6 Months: The PRC provided adequate navigation to substance use programs and/or resources.Agree4 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use6 Months: The PRC provided adequate navigation to substance use programs and/or resources.Neither or N/A0 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use6 Months: The PRC provided adequate navigation to substance use programs and/or resources.Disagree1 Participants
Intervention GroupParticipant Linkage to Care for Opioid Use6 Months: The PRC provided adequate navigation to substance use programs and/or resources.Strongly Disagree0 Participants
Secondary

Participant Linkage to HCV Care

Participants will be interviewed and asked investigator developed questions about linkage to HCV care

Time frame: 6 months

Population: Only 9 participants were eligible for HCV treatment as they tested positive for HCV.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention GroupParticipant Linkage to HCV CareParticipants engaged in HCV treatment at time of enrollment.0 Participants
Intervention GroupParticipant Linkage to HCV CareParticipants receiving or had completed HCV treatment at 6 months.2 Participants
Secondary

Participant Linkage to HIV Care

Participants will be interviewed and asked investigator developed questions about linkage to HIV care

Time frame: 3 months and 6 months

Population: At 3 months 31 participants retained in the study, but only 16 participants completed the 3 month satisfaction survey due to unable to contact all participants.~At 6 months 29 participants retained in the study but only 20 completed the 6 month satisfaction survey due to unable to contact all participants.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention GroupParticipant Linkage to HIV Care3 Months: PRC provided access to HIV prevention and PrEP.Strongly Agree9 Participants
Intervention GroupParticipant Linkage to HIV Care3 Months: PRC provided access to HIV prevention and PrEP.Agree5 Participants
Intervention GroupParticipant Linkage to HIV Care3 Months: PRC provided access to HIV prevention and PrEP.Neither/Na2 Participants
Intervention GroupParticipant Linkage to HIV Care3 Months: PRC provided access to HIV prevention and PrEP.Disagree0 Participants
Intervention GroupParticipant Linkage to HIV Care3 Months: PRC provided access to HIV prevention and PrEP.Strongly0 Participants
Intervention GroupParticipant Linkage to HIV Care6 Months: PRC provided access to HIV prevention and PrEP.Strongly Agree12 Participants
Intervention GroupParticipant Linkage to HIV Care6 Months: PRC provided access to HIV prevention and PrEP.Agree7 Participants
Intervention GroupParticipant Linkage to HIV Care6 Months: PRC provided access to HIV prevention and PrEP.Neither/Na1 Participants
Intervention GroupParticipant Linkage to HIV Care6 Months: PRC provided access to HIV prevention and PrEP.Disagree0 Participants
Intervention GroupParticipant Linkage to HIV Care6 Months: PRC provided access to HIV prevention and PrEP.Strongly0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026